C. Morgan

First name
C.
Middle name
L.
Last name
Morgan
Heywood, B. R., Morgan, C. L., Berni, T. R., Summers, D. R., Jones, B. I., Jenkins-Jones, S., et al. (2023). Real-world evidence from the first online healthcare analytics platform-Livingstone. Validation of its descriptive epidemiology module. Plos Digit Health, 2, e0000310. http://doi.org/10.1371/journal.pdig.0000310
View
Morgan, C. L., Thomas, M., Ständer, S., Jabbar-Lopez, Z. K., Piketty, C., Gabriel, S., et al. (2022). Epidemiology of prurigo nodularis in England: a retrospective database analysis. Br J Dermatol. http://doi.org/10.1111/bjd.21032
View
Morgan, C. L., Jenkins-Jones, S., Evans, M., Barnett, A. H., Poole, C. D., & Currie, C. J. (2012). Weight change in people with type 2 diabetes: secular trends and the impact of alternative antihyperglycaemic drugs. Diabetes Obes Metab. http://doi.org/10.1111/j.1463-1326.2011.01552.x
View
Morgan, C. L., Poole, C. D., Evans, M., Barnett, A. H., Jenkins-Jones, S., & Currie, C. J. (2012). What next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetes. J Clin Endocrinol Metab. http://doi.org/10.1210/jc.2012-3034
View
Morgan, C. L., Jenkins-Jones, S., Currie, C. J., & Rees, D. A. (2012). Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study. J Clin Endocrinol Metab. http://doi.org/10.1210/jc.2012-1690
View
Holden, S. E., Jenkins-Jones, S., Poole, C. D., Morgan, C. L., Coghill, D., & Currie, C. J. (2013). The prevalence and incidence, resource use and financial costs of treating people with attention deficit/hyperactivity disorder (ADHD) in the United Kingdom (1998 to 2010). Child Adolesc Psychiatry Ment Health. http://doi.org/10.1186/1753-2000-7-34
View
Morgan, C. L., Owens, D. R., Aubonnet, P., Carr, E. S., Jenkins-Jones, S., Poole, C. D., & Currie, C. J. (2013). Primary prevention of diabetic retinopathy with fibrates: a retrospective, matched cohort study. BMJ Open. http://doi.org/10.1136/bmjopen-2013-004025
View
Holden, S. H., Barnett, A. H., Peters, J. R., Jenkins-Jones, S., Poole, C. D., Morgan, C. L., & Currie, C. J. (2013). The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010. Diabetes Obes Metab. http://doi.org/10.1111/dom.12123
View
Currie, C. J., Poole, C. D., Evans, M., Peters, J. R., & Morgan, C. L. (2013). Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes. J Clin Endocrinol Metab. http://doi.org/10.1210/jc.2012-3042
View
Morgan, C. L., Puelles, J., Poole, C. D., & Currie, C. J. (2014). The effect of withdrawal of rosiglitazone on treatment pathways, diabetes control and patient outcomes: a retrospective cohort study. J Diabetes Complications. http://doi.org/10.1016/j.jdiacomp.2014.01.007
View